-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
Face amount or stated value per share of common stock.
-
Summary
-
Chromocell Therapeutics Corp quarterly Common Stock, Par or Stated Value Per Share history and growth rate from Q2 2022 to Q3 2024.
- Chromocell Therapeutics Corp Common Stock, Par or Stated Value Per Share for the quarter ending September 30, 2024 was 0 USD/shares.
Common Stock, Par or Stated Value Per Share, Quarterly (USD/shares)
Common Stock, Par or Stated Value Per Share, YoY Quarterly Growth (%)